Week Ahead: Fed Decision, Big Tech Earnings, and the Busiest Five Days of Q4 Season
Investors brace for a pivotal week with the Fed's January meeting, earnings from Microsoft, Meta, Tesla, and Apple, and key economic data shaping market direction.
TRENDING TOPICS
1716 articles found for "passive income"
Investors brace for a pivotal week with the Fed's January meeting, earnings from Microsoft, Meta, Tesla, and Apple, and key economic data shaping market direction.
In a historic reversal, college tuition costs rose just 1.5% in 2025 while general inflation ran at 2.7%. Experts say demographic pressures and competition are reshaping higher education pricing.
Americans now carry a record $1.21 trillion in credit card debt, with most balances tied to necessities like groceries and utilities rather than discretionary spending.
Texas Instruments is set to report Q4 2025 earnings on January 27, with analysts expecting stabilization in the automotive and industrial segments that comprise 70% of revenue.
For the first time in decades, every major Wall Street bank forecasts positive returns for the S&P 500 in 2026, with targets ranging from 7,100 to 8,100.
Flash PMI data shows Europe's manufacturing downturn easing, with Germany's factory sector improving to 48.7 while France unexpectedly contracts at 48.6.
The Federal Reserve's first meeting of 2026 is expected to result in unchanged rates at 3.50%-3.75%. Here's what investors should watch for in next week's FOMC decision.
The power equipment giant raised its quarterly payout to $0.50 per share and boosted its repurchase authorization as demand for grid infrastructure and data center power surges.
The housing market hit a wall in December as contract signings fell sharply across all regions, ending a four-month streak of gains and dampening the 2026 outlook.
Moody's projects real consumer spending will decelerate to about 1.5% this year as high prices and reduced savings push Americans to prioritize deals and necessities.
The Biden-era Medicare negotiation framework goes into effect, capping costs for Zepbound and similar obesity medications for seniors at $50/month starting April 1.
The University of Michigan's final January consumer sentiment reading came in at 56.4, above expectations of 54.0, as one-year inflation expectations dropped to 4.0%.